2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 min sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️
·19 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
·21 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
·21 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png- ·1 päivä sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=m
It's a bit paradoxical that Novo itself had to withdraw a Wegovy advertisement because they had been a bit too creative. Let the court speak before you judge LLY.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 min sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️
- ·19 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
- ·21 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
- ·21 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png
- ·1 päivä sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=mIt's a bit paradoxical that Novo itself had to withdraw a Wegovy advertisement because they had been a bit too creative. Let the court speak before you judge LLY.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 min sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️
- ·19 t sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
- ·21 t sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
- ·21 t sittenIt is important that Danish-taxed private investors in free portfolios follow their investment plans and realize capital losses when they, for example, hit 5%; but it is also important to have a plan for reinvesting the proceeds. The proceeds should be used to buy new positions, and they should never be used to impair position gain shares on the portfolio's existing positions. If one is not able to follow their "stop loss investment plan", one will get a red loss ladder to the left of the green gain ladder and cheat oneself out of a tax offset of 42% of the realized capital losses: https://cdn.prod.nntech.io/shareville-media/groups/b18bc438-9572-45a1-addf-a5ca95abec68/logos/95fab8b7-9425-475f-b6c5-b9f7112c7242.png
- ·1 päivä sitten · MuokattuStrong and professional interview with Novo Nordisk, which among other things states that there is no excuse for Lilly consistently comparing older Novo data with New Lilly data. Something that in the end can mean that patients and doctors make incorrect professional decisions. https://m.youtube.com/watch?v=MQIoHsCWSxw&pp=ygUJTm92byBzdWVz0gcJCaMLAYcqIYzv&ra=mIt's a bit paradoxical that Novo itself had to withdraw a Wegovy advertisement because they had been a bit too creative. Let the court speak before you judge LLY.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt